Tom O'Lenic

Tom O'Lenic is the Chief Executive Officer of RedShiftBio, where they are revolutionizing biomolecule characterization and bioprocessing analytics. They also serve as a Senior Business Advisor for Protein Fluidics, Inc. and Acepix Biosciences, Inc., and as Executive Chairman of the Board for GenTegra LLC. In prior leadership roles, they held Chief Commercial Officer positions at Omniome and Advanced Cell Diagnostics, and led Global Sales and Service as Sr. VP at MDS AT (Molecular Devices). As a C-level executive, they created more than $1B in exit value.